ABSENCE OF RHODAMINE 123-PHOTOCHEMOTOXICITY IN HUMAN TUMOR XENOGRAFTS

被引:0
|
作者
RIS, HB
ALTERMATT, HJ
SCHAFFNER, T
LIM, CK
POTTER, WR
ALTHAUS, U
机构
[1] MRC LABS,SURREY GU1 1BA,ENGLAND
[2] UNIV BERN,INSELSPITAL,SCH MED,DEPT PATHOL,CH-3010 BERN,SWITZERLAND
[3] ROSWELL PK CANC CTR,DEPT RADIAT BIOL,BUFFALO,NY 14200
关键词
ANIMAL MODEL; HYPERTHERMIA; LASER; NUDE MOUSE; SQUAMOUS CELL CARCINOMA; TRANSPLANTATION;
D O I
10.1002/lsm.1900130109
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Rhodamine 123 (R123)-photochemotoxicity was assessed in BALB/c nude mice bearing a xenografted human squamous cell carcinoma at various power densities and wavelengths and a given incident fluence of 150 Joules/cm2. One hour before light delivery, 1 mg R123/kg was injected i.p. in 20 animals. Surface irradiance was performed on the tumor and an equal size hind leg area of 40 animals. Three groups of 10 animals were treated at 514.5 nm and 0.1 W/cm2, 1 W/cm2, and 30 W/cm2, and one at 488 nm and 30 W/cm2. In each group, five animals received R123. The R123 concentration was measured in the tumor (0.023 +/- 0.007 mug/g) and tumor-free tissue (0.023 +/- 0.008 mug/g) in three additional animals by high performance liquid chromatography 1 hour after R123-administration. Histologic assessment 72 hours after light delivery revealed no tissue damage at nonthermal power densities, either in the tumor or in the tumor-free tissue, irrespective of R123-administration. At 30 W/cm2, neither in the tumor nor in tumor-free tissues was there any significant difference in the depth of necrosis, irrespective of R123-administration and the wavelength applied. Our results question the validity of R123 as a photosensitizer, at least in this rodent tumor model.
引用
收藏
页码:40 / 44
页数:5
相关论文
共 50 条
  • [21] Protocols for the treatment of human tumor xenografts with camptothecins
    Giovanella, BC
    Natelson, E
    Harris, N
    Vardeman, D
    Stehlin, JS
    CAMPTOTHECINS: FROM DISCOVERY TO THE PATIENT, 1996, 803 : 181 - 187
  • [22] CHEMOSENSITIVITY OF HUMAN BREAST-TUMOR XENOGRAFTS
    BAILEY, MJ
    SMITH, I
    STEEL, G
    BRITISH JOURNAL OF CANCER, 1980, 42 (01) : 173 - 173
  • [23] ASSESSMENT OF CHEMOSENSITIVITY IN HUMAN-TUMOR XENOGRAFTS
    STEEL, GG
    BATEMAN, AE
    COURTENAY, VD
    SELBY, PJ
    SHORTHOUSE, AJ
    CELL AND TISSUE KINETICS, 1980, 13 (02): : 214 - 214
  • [24] Establishment of human tumor xenografts in immunodeficient mice
    Christopher L Morton
    Peter J Houghton
    Nature Protocols, 2007, 2 : 247 - 250
  • [25] HUMAN-TUMOR XENOGRAFTS IN RADIOTHERAPEUTIC RESEARCH
    ROFSTAD, EK
    RADIOTHERAPY AND ONCOLOGY, 1985, 3 (01) : 35 - 46
  • [26] Photophysical, photochemical, and tumor-selectivity properties of bromine derivatives of rhodamine-123
    Lacerda, SHD
    Abraham, B
    Stringfellow, TC
    Indig, GL
    PHOTOCHEMISTRY AND PHOTOBIOLOGY, 2005, 81 (06) : 1430 - 1438
  • [27] Intralesional radiolabeled human monoclonal IgM in human tumor xenografts
    Borchardt, PE
    Quadri, SM
    Freedman, RS
    Vriesendorp, HM
    RADIOTHERAPY AND ONCOLOGY, 1997, 44 (03) : 283 - 293
  • [28] Engineered human tumor xenografts with functional human vascular networks
    Alonso-Camino, Vanesa
    Santos-Valle, Patricia
    Carmen Ispizua, Maria
    Sanz, Laura
    Alvarez-Vallina, Luis
    MICROVASCULAR RESEARCH, 2011, 81 (01) : 18 - 25
  • [29] THE EFFECT OF RHODAMINE-123 ON THE R-3372-H PROSTATE TUMOR AND ON THE TISSUES OF THE RAT BEARING THAT TUMOR
    ARCADI, JA
    WHITTIER, MD
    JOURNAL OF UROLOGY, 1987, 137 (04): : A369 - A369
  • [30] CRYOPRESERVATION OF HUMAN-SPERMATOZOA - AN ASSESSMENT OF METHODOLOGY USING RHODAMINE-123
    TUCKER, MJ
    AHUJA, K
    STEVENS, PA
    CRAFT, IL
    ARCHIVES OF ANDROLOGY, 1986, 17 (03): : 179 - 187